Skip to main navigation menu Skip to main content Skip to site footer

Use of Complementary and Alternative Medicine by Oncology Patients in the City of Bucaramanga, Colombia

Uso de Medicina Complementaria y Alternativa en Pacientes Oncológicos en la Ciudad de Bucaramanga, Colombia



Open | Download


Section
Research Article

How to Cite
1.
Martínez-Ramos N, Serrano Díaz NC, Uribe-Pérez CJ, Quintero-Lesmes DC, Mariño-Manrique C, Murillo R. Use of Complementary and Alternative Medicine by Oncology Patients in the City of Bucaramanga, Colombia. Rev. Investig. Innov. Cienc. Salud [Internet]. 2025 Apr. 8 [cited 2025 Jun. 6];7(2):1-15. Available from: https://riics.info/index.php/RCMC/article/view/377

Dimensions
PlumX

Nicolás Martínez-Ramos,

Facultad de Ciencias; Pontificia Universidad Javeriana; Bogotá; Colombia.


Norma Cecilia Serrano Díaz,

Fundación Cardiovascular de Colombia; Floridablanca; Colombia.


Claudia Janeth Uribe-Pérez,

Universidad Autónoma de Bucaramanga; Bucaramanga; Colombia.


Doris Cristina Quintero-Lesmes,

Fundación Cardiovascular de Colombia; Floridablanca; Colombia.


Carolina Mariño-Manrique,

Statistics and Operative research; Universidad de Valencia; Valencia; España.


Raúl Murillo,

1 Facultad de Medicina; Pontificia Universidad Javeriana; Bogotá; Colombia.
2 Centro Javeriano de Oncología; Hospital Universitario San Ignacio; Bogotá; Colombia.


Introduction. Complementary and alternative medicine (CAM) is frequently used by oncology patients worldwide, often alongside conventional treatments. Understanding the frequency of use and motivations for CAM use is essential to improve patient-centered cancer care and guidance.

Objective. To determine the frequency of use of complementary and alternative medicine (CAM) in oncology patients in the city of Bucaramanga, Colombia.

Method. Descriptive study; patients were surveyed at a health center in Bucaramanga, Colombia. Adult patients with any type of cancer, at all clinical stages, and who were undergoing active treatment were included.

Results. A total of 528 patients were included. Seventy-one percent were women, with an average age of 56.6 years. The most common cancer diagnoses were breast, colon, and stomach neoplasms. The CAM’s frequency of use was 67%, the majority of whom were women and patients with an educational level close to primary school. The primary reason for use was for palliative purposes, but a significant number used it for a curative purpose. The most commonly used products by patients were special foods of natural origin, including soursop and soursop leaves. As the main source of information about CAM, 86% reported obtaining this information from people other than the healthcare team.

Conclusion. A high proportion of oncology patients undergoing active treatment use CAM. It is necessary to incorporate this information into patient care and to develop services that guide such practices.


Article visits 152 | PDF visits 78


  1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Globocan 2022 [Internet]. Lyon: International Agency for Research on Cancer; 2024 [cited 2024 Nov 20]. 1 p. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf
  2. Tangkiatkumjai M, Boardman HF, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther [Internet]. 2020;20(1):363. doi: https://doi.org/10.1186/s12906-020-03157-2 DOI: https://doi.org/10.1186/s12906-020-03157-2
  3. National Center for Complementary and Integrative Health (NCCIH) [Internet]. Bethesda: National Institutes of Health (NIH); c2025. Statistics on Complementary and Integrative Health Approaches; 2025 Mar 3 [cited 2025 Feb 3]; [about 2 screens]. Available from: https://www.nccih.nih.gov/research/statistics-on-complementary-and-integrative-health-approaches
  4. Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract [Internet]. 2012;66(10):924-39. doi: https://doi.org/10.1111/j.1742-1241.2012.02945.x DOI: https://doi.org/10.1111/j.1742-1241.2012.02945.x
  5. Sánchez R, Ibáñez CPB, Suárez A. Utilización de terapias complementarias y alternativas en niños con cáncer. Rev salud pública [Internet]. 2015;17(5):699-712. doi: https://doi.org/10.15446/rsap.v17n5.38695 DOI: https://doi.org/10.15446/rsap.v17n5.38695
  6. Sánchez R, Venegas M. Aproximaciones complementarias y alternativas al cuidado de la salud en el Instituto Nacional de Cancerología: estudio de prevalencia. Rev Colomb Cancerol [Internet]. 2010;14(3):135-43. doi: https://doi.org/10.1016/S0123-9015(10)70094-9 DOI: https://doi.org/10.1016/S0123-9015(10)70094-9
  7. Abuelgasim KA, Alsharhan Y, Alenzi T, Alhazzani A, Ali YZ, Jazieh AR. The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. BMC Complement Altern Med [Internet]. 2018;18(1):88. doi: https://doi.org/10.1186/s12906-018-2150-8 DOI: https://doi.org/10.1186/s12906-018-2150-8
  8. Guerra-Martín MD, Tejedor-Bueno MS, Correa-Casado M. Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review. Int J Environ Res Public Health [Internet]. 2021;18(3):1-10. doi: https://doi.org/10.3390/ijerph18031017 DOI: https://doi.org/10.3390/ijerph18031017
  9. Kristoffersen AE, Nilsen JV, Stub T, Nordberg JH, Wider B, Mora DC, et al. Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway. BMC Complement Med Ther [Internet]. 2022;22(1):202. doi: https://doi.org/10.1186/s12906-022-03606-0 DOI: https://doi.org/10.1186/s12906-022-03606-0
  10. Adams M, Jewell A. The use of complementary and alternative medicine by cancer patients. Int Semin Surg Oncol [Internet]. 2007;4:10. doi: https://doi.org/10.1186/1477-7800-4-10 DOI: https://doi.org/10.1186/1477-7800-4-10
  11. García-Padilla P, García-Padilla D, Ramírez-Castro MF, Pulido-Rincón P, Murillo R. Patient–doctor interactions around alternative and complementary medicine in the context of oncology care in a Latin American country. Complement Ther Med [Internet]. 2023;78:102986. doi: https://doi.org/10.1016/j.ctim.2023.102986 DOI: https://doi.org/10.1016/j.ctim.2023.102986
  12. Mora DC, Kristoffersen AE, Overvåg G, Jong MC, Mentink M, Liu J, et al. Safety of Complementary and Alternative Medicine (CAM) treatment among children and young adults who suffer from adverse effects of conventional cancer treatment: A systematic review. Integr Cancer Ther [Internet]. 2022;21. doi: https://doi.org/10.1177/15347354221105563 DOI: https://doi.org/10.1177/15347354221105563
  13. Sweet ES, Standish LJ, Goff BA, Andersen MR. Adverse Events Associated With Complementary and Alternative Medicine Use in Ovarian Cancer Patients. Integr Cancer Ther [Internet]. 2013;12:508-16. doi: https://doi.org/10.1177/1534735413485815 DOI: https://doi.org/10.1177/1534735413485815
  14. Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the MDM2 Oncogene through the PI3K/mTOR/ETS2 Pathway. Cancer Res [Internet]. 2007;67(5):1988-96. doi: https://doi.org/10.1158/0008-5472.CAN-06-3066 DOI: https://doi.org/10.1158/0008-5472.CAN-06-3066
  15. Murillo N, Lasso P, Urueña C, Pardo-Rodriguez D, Ballesteros-Ramírez R, Betancourt G, et al. Petiveria alliacea Reduces Tumor Burden and Metastasis and Regulates the Peripheral Immune Response in a Murine Myeloid Leukemia Model. Int J Mol Sci [Internet]. 2023;24(16):12972. doi: https://doi.org/10.3390/ijms241612972 DOI: https://doi.org/10.3390/ijms241612972
  16. Bravo LE, Muñoz N. Epidemiology of cancer in Colombia. Colomb Med[Internet]. 2018;49(1):9-12. doi: https://doi.org/10.25100/cm.v49i1.3877 DOI: https://doi.org/10.25100/cm.v49i1.3877
  17. Uribe Pérez CJ, Serrano-Gómez S, Hormiga Sánchez CM. Cancer incidence and mortality in Bucaramanga, Colombia. 2008-2012. Colomb Med [Internet]. 2018;49(1):73-80. doi: https://doi.org/10.25100/cm.v49i1.3632 DOI: https://doi.org/10.25100/cm.v49i1.3632
  18. Pardo C, Cendales R. Incidencia, mortalidad y prevalencia de cáncer en Colombia, 2012-2016. Vol 1 [Internet]. Bogotá: Instituto Nacional de Cancerología; 2022 [cited 2025 Feb 3]. 159 p. Available from: https://www.cancer.gov.co/conozca-sobre-cancer-1/publicaciones/incidencia-mortalidad-prevalencia-cancer-2-1
  19. Uribe Pérez CJ, Amado Niño AM, Rueda Patiño AM. Barreras para la atención en salud del cáncer gástrico, Santander, Colombia. Etapa exploratoria. Rev Colomb Gastroenterol [Internet]. 2019;34(1):17-22. doi: https://doi.org/10.22516/25007440.353 DOI: https://doi.org/10.22516/25007440.353
  20. Källman M, Bergström S, Carlsson T, Järås J, Holgersson G, Nordberg JH, et al. Use of CAM among cancer patients. BMC Complement Med Ther [Internet]. 2023;23(1):51. doi: https://doi.org/10.1186/s12906-023-03876-2 DOI: https://doi.org/10.1186/s12906-023-03876-2
  21. Stub T, Quandt SA, Kristoffersen AE, Jong MC, Arcury TA. Communication and information needs about complementary and alternative medicine: a qualitative study of parents of children with cancer. BMC Complement Med Ther [Internet]. 2021;21(1):85. doi: https://doi.org/10.1186/s12906-021-03253-x DOI: https://doi.org/10.1186/s12906-021-03253-x
  22. Wang SY, Lin LW, Chang YY, Huang YP. Health care professionals’ interactions with cancer patients who use complementary and alternative medicine in Taiwan. Collegian [Internet]. 2016;23(2):209-16. doi: https://doi.org/10.1016/j.colegn.2015.02.007 DOI: https://doi.org/10.1016/j.colegn.2015.02.007
  23. Murillo R, Pinto-Martínez N, Serrano N, Uribe C, Navarro E, Duque J, et al. Use of complementary and alternative medicine by cancer patients in Colombia. BMC Complement Med Ther [Internet]. 2023;23(1):321. doi: https://doi.org/10.1186/s12906-023-04144-z DOI: https://doi.org/10.1186/s12906-023-04144-z
  24. National Center for Complementary and Integrative Health (NCCIH) [Internet]. Bethesda: National Institutes of Health (NIH); c2025. Salud complementaria, alternativa o integral: ¿Qué hay detrás de estos nombres? 2025 Mar 3 [cited 2025 Feb 3]; [about 12 screens]. Available from: https://www.nccih.nih.gov/health/espanol/salud-complementaria-alternativa-o-integral-que-significan-estos-terminos
  25. García-Padilla P, Ordóñez Reyes C, Medina P, Fernández Deaza G, Morales OL, Murillo R. Perspectivas de pacientes y profesionales en torno al uso de medicinas alternativas y complementarias para el cuidado del cáncer: un estudio exploratorio. Univ Med [Internet]. 2021;62(1):1-12. doi: https://doi.org/10.11144/javeriana.umed62-1.pppu DOI: https://doi.org/10.11144/Javeriana.umed62-1.pppu
  26. Zapata-Ossa H de J, Cubides-Munévar AM, López MC, Pinzón-Gómez EM, Filigrana-Villegas PA, Cassiani-Miranda CA. Muestreo por conglomerados en encuestas poblacionales. Rev salud pública [Internet]. 2011;13(1):141-51. Available from: https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/33543
  27. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform [Internet]. 2009;42(2):377-81. doi: https://doi.org/10.1016/j.jbi.2008.08.010 DOI: https://doi.org/10.1016/j.jbi.2008.08.010
  28. Lopez G, Salas CA, Cadiz F, Barriga C, Gonzalez P, Acevedo S, et al. Complementary and Integrative Medicine Use in Individuals Seeking Conventional Medical Oncology Care in Chile: Prevalence and Patient Characteristics. J Glob Oncol [Internet]. 2019;5:1-6. doi: https://doi.org/10.1200/JGO.18.00190 DOI: https://doi.org/10.1200/JGO.18.00190
  29. Idoyaga Molina N, Luxardo N. Medicinas no convencionales en cáncer. Med B Aires [Internet]. 2005;65(5):390-4. Available from: https://www.scielo.org.ar/scielo.php?pid=S0025-76802005000500002&script=sci_abstract&tlng=en
  30. Bahall M. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study. BMC Complement Altern Med [Internet]. 2017;17(1):345. doi: https://doi.org/10.1186/s12906-017-1853-6 DOI: https://doi.org/10.1186/s12906-017-1853-6
  31. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol [Internet]. 2005;16(4):655-63. doi: https://doi.org/10.1093/annonc/mdi110 DOI: https://doi.org/10.1093/annonc/mdi110
  32. Wode K, Henriksson R, Sharp L, Stoltenberg A, Nordberg JH. Cancer patients’ use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med [Internet]. 2019;19(1):62. doi: https://doi.org/10.1186/s12906-019-2452-5 DOI: https://doi.org/10.1186/s12906-019-2452-5
  33. Romero-García PA, Ramirez-Perez S, Miguel-González JJ, Guzmán-Silahua S, Castañeda-Moreno JA, Komninou S, et al. Complementary and Alternative Medicine (CAM) Practices: A Narrative Review Elucidating the Impact on Healthcare Systems, Mechanisms and Paediatric Applications. Healthcare (Basel) [Internet]. 2024;12(15):1-26. doi: https://doi.org/10.3390/healthcare12151547 DOI: https://doi.org/10.3390/healthcare12151547
  34. Hailemeskel B, Ziregbe E, Tran CF, Pharmd SBW, Ahari-Lahagh A, Kumarra S, et al. Complementary and Alternative Medicine (CAM) Utilization by Howard University (HU) First Year Pharmacy Students: Survey and Review of Most Commonly Used Herbs. Curr Res Integr Med [Internet]. 2017;2(3):37-41. Available from: https://www.pulsus.com/abstract/complementary-and-alternative-medicine-cam-utilization-by-howard-university-hu-first-year-pharmacy-students-survey-andrn-3980.html
  35. Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer [Internet]. 2005;13(10):806-11. doi: https://doi.org/10.1007/s00520-004-0770-7 DOI: https://doi.org/10.1007/s00520-004-0770-7
  36. Marshik PL, Kharat AA, Jakeman B, Borrego ME, Dodd MA, Bachyrycz A, et al. Complementary and Alternative Medicine and Therapy Use in a Diverse New Mexican Population. J Altern Complement Med [Internet]. 2016;22(1):45-51. doi: https://doi.org/10.1089/acm.2014.0378 DOI: https://doi.org/10.1089/acm.2014.0378
  37. Nissen NK. Challenging perspectives: Women, complementary and alternative medicine, and social change. Interface [Internet]. 2011;3(2):187-212. Available from: http://www.interfacejournal.net/wordpress/wp-content/uploads/2011/12/Interface-3-2-Nissen.pdf
  38. Alwhaibi M, AlRuthia Y, Meraya AM. Gender Differences in the Prevalence of Complementary and Alternative Medicine Utilization among Adults with Arthritis in the United States. Evid Based Complement Alternat Med [Internet]. 2019:8739170. doi: https://doi.org/10.1155/2019/8739170 DOI: https://doi.org/10.1155/2019/8739170
  39. Bari S, Chineke I, Darwin A, Umar A, Jim H, Muzaffar J, et al. Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population. Integr Cancer Ther [Internet]. 2021;20: 15347354211051622. doi: https://doi.org/10.1177/15347354211051622 DOI: https://doi.org/10.1177/15347354211051622
  40. Dufter SA, Hübner J, Ahmadi E, Zomorodbakhsch B. Traits of cancer patients and CAM usage. J Cancer Res Clin Oncol [Internet]. 2021;147(12):3685-92. doi: https://doi.org/10.1007/s00432-021-03605-7 DOI: https://doi.org/10.1007/s00432-021-03605-7
  41. Kim K, Kim SH, Ok ON, Kim IR, Lee S, Kim SH, et al. Use of complementary and alternative medicine by lymphoma survivors in South Korea. Eur J Oncol Nurs [Internet]. 2018;33:91-6. doi: https://doi.org/10.1016/j.ejon.2018.01.012 DOI: https://doi.org/10.1016/j.ejon.2018.01.012
  42. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents. J Clin Oncol [Internet]. 2004;22(12):2489-503. doi: https://doi.org/10.1200/JCO.2004.08.182 DOI: https://doi.org/10.1200/JCO.2004.08.182
  43. Gavamukulya Y, Wamunyokoli F, El-Shemy HA. Annona muricata: Is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac J Trop Med [Internet]. 2017;10(9):835-48. doi: https://doi.org/10.1016/j.apjtm.2017.08.009 DOI: https://doi.org/10.1016/j.apjtm.2017.08.009
  44. Gu I, Brownmiller C, Howard L, Lee SO. Chemical Composition of Volatile Extracts From Blackberries, Black Raspberries, and Blueberries and Their Apoptotic Effect on A549 Non-Small-Cell Lung Cancer Cells. Curr Dev Nutr [Internet]. 2022;6(Suppl 1):284. doi: https://doi.org/10.1093/cdn/nzac053.025 DOI: https://doi.org/10.1093/cdn/nzac053.025
  45. Hoshyar R, Mahboob Z, Zarban A. The antioxidant and chemical properties of Berberis vulgaris and its cytotoxic effect on human breast carcinoma cells. Cytotechnology [Internet]. 2016;68(4):1207-13. doi: https://doi.org/10.1007/s10616-015-9880-y DOI: https://doi.org/10.1007/s10616-015-9880-y
  46. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, et al. Use of Complementary/Alternative Medicine by Breast Cancer Survivors in Ontario: Prevalence and Perceptions. J Clin Oncol [Internet]. 2000;18(13):2515-21. doi: https://doi.org/10.1200/JCO.2000.18.13.2515 DOI: https://doi.org/10.1200/JCO.2000.18.13.2515
  47. Martínez-Ramos N, Mariño C, Olaya-SanMiguel LC, Murillo R. (2024). Use of Alternative Medicine in Cancer Patients in the City of Neiva (Colombia). Univ Med [Internet]. 2024;65. doi: https://doi.org/10.11144/Javeriana.umed65.umap DOI: https://doi.org/10.11144/Javeriana.umed65.umap
  48. Asiimwe JB, Nagendrappa PB, Atukunda EC, Kamatenesi MM, Nambozi G, Tolo CU, et al. Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis. Evid-Based Complement Alternat Med [Internet]. 2021: 9963038. doi: https://doi.org/10.1155/2021/9963038 DOI: https://doi.org/10.1155/2021/9963038
Sistema OJS 3.4.0.7 - Metabiblioteca |